[1] Sung H, Ferlay J, Siegel RL, et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. [2] Gerratana L, Fanotto V, Bonotto M, et al.Pattern of metastasis and outcome in patients with breast cancer[J]. Clin Exp Metastasis, 2015, 32(2): 125-133. [3] Igci A, Özkurt E.Management of Isolated Liver Metastasis[M]//Aydiner A, Igci A, Soran A.Breast Disease. Berlin: Springer, 2019: 597-606. [4] Cristofanilli M, Hortobagyi GN.New horizons in treating metastatic disease[J]. Clin Breast Cancer, 2001, 1(4): 276-287. [5] Eng LG, Dawood S, Sopik V, et al.Ten-year survival in women with primary stage IV breast cancer[J]. Breast Cancer Res Treat, 2016, 160(1): 145-152. [6] Adam R, Aloia T, Krissat J, et al.Is liver resection justified for patients with hepatic metastases from breast cancer?[J]. Ann Surg, 2006,244(6):897-907. [7] Khodari W, Sedrati A, Naisse I, et al.Impact of loco-regional treatment on metastatic breast cancer outcome: A review[J]. Crit Rev Oncol Hematol, 2013, 87(1): 69-79. [8] Clements ME, Johnson RW.PREX1 drives spontaneous bone dissemination of ER+ breast cancer cells[J]. Oncogene, 2020, 39(6):1318-1334. [9] Semenza GL.Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis[J]. Oncogene,2013, 32(35):4057-4063. [10] Liu Y, Cao X.Immunosuppressive cells in tumor immune escape and metastasis[J]. J Mol Med, 2015, 94(5): 509-522. [11] Riès STB, Dupuy BF, Dong CZ, et al.Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes[J]. Mol Cell Biol, 2012, 32(15): 2979. [12] Madankumar P, Naveenkumar P, Niranjalidevaraj S.Morin, a dietary flavonoid, exhibited anti-fibrotic effect and induced apoptosis of activated hepatic stellate cells by inhibiting canonical NF-κB signaling[J]. Biochimie, 2015, 110:107-118. [13] National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology:Breast Cancer,version 5[Internet]. Fort Washington, PA:National Comprehensive Cancer Network; 2021.[cited June 28, 2021]. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. [14] Ji L, Cheng L, Zhu X, et al.Risk and prognostic factors of breast cancer with liver metastases[J]. BMC Cancer, 2021, 21(1):238. [15] Cardoso F, Paluch-Shimon S, Senkus E, et al.5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)[J]. Ann Oncol, 2020, 31(12):1623-1649. [16] Bialas M, Pankowska V, Bondos J, et al.Comparative assessment of hypofractionated radiation therapy and standard treatment in patients with prostate cancer[J]. J Clin Oncol, 34, 2016 (suppl): e16616. [17] Goetz MP, Toi M, Campone M, et al.MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer[J]. J Clin Oncol, 2017, 35(32):3638-3646. [18] Pbx A, Pmy B, Pfm A, et al.Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial[J], Lancet Oncol, 2021, 22(3):351-360. [19] Modi S, Saura C, Yamashita T, et al.Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer[J]. N Engl J Med, 2020, 382(7):610-621. [20] Weinrich M, Weiβ C, Schuld J, et al.Liver Resections of Isolated Liver Metastasis in Breast Cancer: Results and Possible Prognostic Factors[J]. HPB Surg, 2014, 2014: 893829. [21] Vertriest C, Berardi G, Tomassini F, et al.Resection of Single Metachronous Liver Metastases from Breast Cancer Stage I-II Yield Excellent Overall and Disease-Free Survival. Single Center Experience and Review of the Literature[J]. Dig Surg, 2015, 32(1): 52-59. [22] Sabol M, Donat R, Chvalny P, et al.Surgical management of breast cancer liver metastases[J]. Neoplasma, 2014, 61(5): 601-606. [23] Ruiz A, Castro-Benitez C, Sebagh M, et al.Repeat Hepatectomy for Breast Cancer Liver Metastases[J]. Ann Surg Oncol, 2015, 22(3): S1057-1066. [24] Ruiz A, van Hillegersberg R, Siesling S, et al. Surgical resection versus systemic therapy for breast cancer liver metastases: Results of a European case matched comparison[J]. Eur J Cancer, 2018, 95: 1-10. [25] Feng Y, He XG, Zhou CM, et al.Comparison of hepatic resection and systemic treatment of breast cancer liver metastases: A propensity score matching study[J]. Am J Surg, 2020, 220(4): 945-951. [26] Kostov DV, Kobakov GL, Yankov DV.Prognostic Factors Related to Surgical Outcome of Liver Metastases of Breast Cancer[J]. J Breast Cancer, 2013, 16(2): 184-192. [27] Margonis GA, Kim Y, Buettner S, et al.The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysis[J]. HPB (Oxford), 2016, 18(8):700-705. [28] Dittmar Y, Altendorf-Hofmann A, Schüle S, et al.Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature[J]. J Cancer Res Clin Oncol, 2013, 139(8):1317-1325. [29] Sakamoto Y, Yamamoto J, Yoshimoto M, et al.Hepatic Resection for Metastatic Breast Cancer: Prognostic Analysis of 34 Patients[J]. World J Surg, 2005, 29(4): 524-527. [30] Howlader M, Heaton N, Rela M.Resection of liver metastases from breast cancer: Towards a management guideline[J]. Int J Surg, 2011, 9(4): 285-291. [31] He X, Zhang Q, Feng Y, et al.Resection of liver metastases from breast cancer: a multicentre analysis[J]. Clin Transl Oncol, 2020, 22(4):512-521. [32] Lermite E, Marzano E, Chéreau E, et al.Surgical resection of liver metastases from breast cancer[J]. Surg Oncol, 2010, 19(4): e79-e84. [33] Nicolae B, Irina B, Veronica I, et al.The Impact on the Long-term Outcomes of Hormonal Status After Hepatic Resection for Breast Cancer Liver Metastases[J]. In Vivo, 2018, 32(5): 1247-1253. [34] Ercolani, Giorgio, Zanello, et al. Ten-Year Survival after Liver Resection for Breast Metastases: A Single-Center Experience[J]. Dig Surg, 2018, 35(4):372-380. [35] Xiao YB, Zhang B, Wu YL.Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis[J]. J Zhejiang Univ Sci B, 2018, 19(11): 829-843. |